6-17421593-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006366.3(CAP2):c.38G>A(p.Arg13Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000209 in 1,614,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006366.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CAP2 | NM_006366.3 | c.38G>A | p.Arg13Gln | missense_variant | 2/13 | ENST00000229922.7 | |
CAP2 | NM_001363534.2 | c.38G>A | p.Arg13Gln | missense_variant | 2/12 | ||
CAP2 | NM_001363533.2 | c.38G>A | p.Arg13Gln | missense_variant | 2/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CAP2 | ENST00000229922.7 | c.38G>A | p.Arg13Gln | missense_variant | 2/13 | 1 | NM_006366.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152136Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000378 AC: 95AN: 251492Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135922
GnomAD4 exome AF: 0.000197 AC: 288AN: 1461818Hom.: 0 Cov.: 31 AF XY: 0.000179 AC XY: 130AN XY: 727228
GnomAD4 genome AF: 0.000328 AC: 50AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74432
ClinVar
Submissions by phenotype
Cardiomyopathy, dilated, 2I Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Clinical Genomics Laboratory, Stanford Medicine | Jun 07, 2021 | The p.Arg13Gln variant in the CAP2 gene has not been previously reported in association with disease. This variant has been identified in 82/25,122 Finnish chromosomes (110/282,866 chromosomes overall) by the Genome Aggregation Database (http://gnomad.broadinstitute.org/). Although this variant has been seen in the general population, it has not been observed at a frequency high enough to rule out pathogenicity. The arginine at position 13 is not evolutionarily conserved and several mammalian species have a glutamine at this position. Computational tools predict that the p.Arg13Gln does not impact protein function; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, the significance of the p.Arg13Gln variant is uncertain. Additional information is needed to resolve the significance of this variant. [ACMG evidence codes used: BP4] - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at